Perrigo shareholders snub drugmaker Mylan's $26 billion hostile bid

(Reuters) - Perrigo Co Plc'sshareholders rejected Mylan NV's$26 billion hostile bid, ending the Netherlands-based generic drug maker's seven-month pursuit of its smaller rival.